How McKinsey helped Purdue Pharma sell OxyContin

Dec 01, 2020

∙ Paid

Gerald Posner talks to Tucker Carlson about the latest revelations about how elite consultants, McKinsey & Company, developed plans to "turbocharge" Purdue's Oxy sales, including one that involved rebates to drug insurance companies based on the number of Oxy addictions and overdose deaths.

Continue reading this post for free, courtesy of Gerald Posner.

Or purchase a paid subscription.